# Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block

> **NCT05097768** · NA · COMPLETED · sponsor: **Alfarabi Colleges** · enrollment: 250 (actual)

## Conditions studied

- Symptomatic Irreversible Pulpitis

## Interventions

- **DRUG:** Dexamethasone 0.5mg
- **DRUG:** Ketorolac 10 Mg Oral Tablet
- **DRUG:** Meloxicam 7.5 mg
- **DRUG:** Ibuprofen 600 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05097768
- **Lead sponsor:** Alfarabi Colleges
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-15
- **Primary completion:** 2022-01-15
- **Final completion:** 2022-01-27
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05097768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05097768, "Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05097768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*